{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-083973","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2024-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.625341+00:00","generated_at":"2026-05-31T15:23:27.541709+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Orchestra BioMed appoints John Mack to board; former Medtronic Cardiac Surgery President","bullets":["John Mack appointed as Class I director effective July 29, 2024; term expires at 2027 annual meeting.","Mack previously served as Medtronic's President of Cardiac Surgery and led business development for its $3.2B coronary/structural heart business.","Appointed to Audit Committee; Board size increased from 7 to 8 directors.","No family relationships or transactions requiring disclosure under Item 404(a).","Mack will receive standard non-employee director compensation per existing policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-083973","json":"https://secwatch.observer/filing/0001104659-24-083973.json","markdown":"https://secwatch.observer/filing/0001104659-24-083973.md","text":"https://secwatch.observer/filing/0001104659-24-083973.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924083973/0001104659-24-083973-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924083973/tm2420397d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:23:27.541709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c254b67fa","claim":"John Mack was appointed as Director at Orchestra BioMed Holdings, Inc..","evidence_excerpt":"On July 29, 2024, the Board of Directors (the “ Board ”) of Orchestra BioMed Holdings, Inc. (the “ Company ”) appointed John Mack to serve as a Class I director, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924083973/0001104659-24-083973-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}